Mathilde Roussel

Mathilde Roussel is currently an Access Strategy Leader at Roche, specializing in onco-hematology. They previously held roles at Roche Pharmaceuticals as a Price and Reimbursement Project Manager and Economic Technical Evidence Lead in Health Economics, Pricing & Business Development. Before that, Mathilde worked as a Consultant in Economic Affairs & Business Development at Nextep Consulting and Health Economics and completed a training period in new product market access at Novartis. Mathilde holds a Master’s degree in Technology & Innovation Management from University Paris IX Dauphine and a Master’s degree in pharmacochemistry, molecular pharmacology, and drug metabolism from University Paris V René Descartes, along with research experience at the National Institute of Health and Medical Research.